27 related news articles for

  • Hudson success in 2024 NHMRC Investigator grants

    Hudson Institute Group Heads, Professor Claudia Nold and Associate Professor Flora Wong were each awarded grants of more than $2 million over the next five years, enabling them to commit long-term to these exciting research projects.…  Read more

    NHMRC 2024 recipients Professor Claudia Nold and Associate Professor Flora Wong
  • How to protect the newborn brain

    A major systematic review of treatments for protecting the newborn brain from the negative effects of inflammation has found that earlier anti-inflammatory intervention is best, but it’s better late than never.…  Read more

    Sharmony Kelly and Dr Robert Galinsky, Perinatal Inflammation and Neurophysiology at Hudson Institute
  • New treatments for preterm babies

    The medical research equivalent of vertical integration is rare – which is why Hudson Institute is fortunate to have husband and-wife team Professors Claudia and Marcel Nold, who are engaged in a hugely beneficial working partnership.…  Read more

    Professors Marcel and Claudia Nold are keeping preterm babies healthy with further research involving medical trials at Hudson Institute.
  • How magnesium sulphate benefits preterm babies

    Being born too soon exposes babies to many dangerous health conditions, and researchers are tackling one of them by finding out how magnesium sulphate can protect the health of the preterm brain.…  Read more

    Dr Robert Galinsky, Research Group Head, Perinatal Inflammation and Neurophysiology at Hudson Institute
  • How the microbiome affects the immune system

    Shining a light on how the lung microbiome in the first days of life can affect the immune system for years to come, Hudson Institute researchers have taken an important first step in an increasingly relevant field of medical study.…  Read more

    Claudia Nold, Marcel Nold, Sara di Simone, Sam Forster and Ina Rudloff in the lab at Hudson Insitute
  • Preventing brain damage in preterm babies

    Hudson Institute researchers have conducted the first attempts to collect umbilical cord blood cells from very preterm babies, with a view to using them to reduce their increased risk of brain injury and disability.…  Read more

    Dr Lindsay Zhou from the Neurodevelopment and Neuroprotection Research Group at Hudson Institute of Medical Research
  • Hudson News Summer 2022

    This is the time of year when we look back at what we have achieved and acknowledge the people who helped us make it happen. …  Read more

    Professor Elizabeth Hartland
  • Special delivery – keeping preterm babies healthy

    When baby Max arrived – early and in a hurry – no-one realised he would play a vital part in keeping other preterm babies healthy in the future.…  Read more

    Suzana tells her story on the safe arrival of baby Max and praises Hudson Institute researchers keeping preterm babies healthy.
  • Finding and treating newborn brain injury

    The long-term effects of newborn brain injuries are well known, so Professor Suzanne Miller’s dream is to be able to detect and treat those injuries in time to make a difference.…  Read more

    Professor Suzanne Miller's research aims at detecting and treating newborn brain injury in time to make a difference to their lives.
  • Importance of donor age in treating BPD

    An effective treatment is closer than ever for one of the most devastating conditions affecting premature babies, with researchers at Hudson Institute further refining their world-first method of treating BPD (Bronchopulmonary dysplasia).…  Read more

    Associate Professor Rebecca Lim researching in the lab on an effective treatment for treating BPD (Bronchopulmonary dysplasia).
  • Treatment hope for premature babies

    A treatment offering hope to parents of very premature babies is showing great promise, in the first worldwide stocktake of research into umbilical cord blood stem cells.…  Read more

    Dr Lindsay Zhou and researchers at Hudson Institute have reviewed all current research into umbilical cord blood stem cells treatment, which offers hope to premature babies.
  • Helping pre-term babies avoid bronchopulmonary dysplasia by controlling inflammatory response

    Medical researchers are a big step closer to understanding the inflammatory responses in pre-term babies that can cause devastating heart and lung conditions including bronchopulmonary dysplasia (BPD) and pulmonary hypertension (PH).…  Read more

    Professor Claudia Nold and Professor Marcel Nold from The Ritchie Centre at Hudson Institute of Medical Research
  • Study revolutionises cell therapy for premature babies

    Research into a chronic lung disease in premature babies is leading Hudson Institute researchers to develop new protocols on how to treat infants with cell-based therapies. …  Read more

    Associate Professor Rebecca Lim, Cell Therapy Researcher, Hudson Institute of Medical Research
  • Helping preterm babies avoid brain damage

    High-tech images have revealed for the first time that preterm babies on ventilators could be at risk of brain injury, leading to calls for caution during treatment.…  Read more

    Associate Professor Flora Wong from the Neonatal Brian Protection Research Group at Hudson Institute
  • Stem cell therapy advances lung disease treatment

    A cutting-edge new treatment for a fatal lung disease is one step closer thanks to a discovery by Hudson Institute stem cell therapy researchers.…  Read more

    Dandan Zhu and Rebecca Lim at Hudson Institute
  • Funding boost to develop lung treatment for premature babies

    Associate Professor Rebecca Lim has been awarded $300,000 from the Victorian Medical Research Acceleration Fund to progress her laboratory’s research into a new regenerative medicine,…  Read more

    Associate Professor Rebecca Lim from the Amnion Cell Biology Research Group at Hudson Institute
  • Stem cells help premature babies with lung disease

    Hudson Institute and Monash University researchers have assessed the long-term outcomes of their world-first study that used placental stem cells in premature babies with severe bronchopulmonary dysplasia, a form of chronic lung disease.…  Read more

    Dr Atul Malhotra, an Honorary Clinical Associate in the Neurodevelopment and Neuroprotection Research Group at Hudson Institute
  • Taking the pressure off little lungs and hearts

    New research into an anti-inflammatory drug for treating lung disease in pre-term babies has shown it also has the potential to prevent the disease’s subsequent complication, pulmonary hypertension (PH), a vascular condition that leads to heart failure and death in 50 per cent of cases.…  Read more

    Associate Professor Claudia Nold from the Interventional Immunology in Early Life Diseases Research Group at Hudson Institute
  • Contribution to human health top-ranked

    Associate Professor Rebecca Lim is now formally among the top scientists in Australia after being ranked the highest applicant in the industry category for the 2018 National Health and Medical Research Council (NHMRC) Career Development Fellowship Scheme. The award is given to the highest ranked applicant in the biomedical, clinical, industry and population health pillars…  Read more

    Associate Professor Rebecca Lim from the Amnion Cell Biology Research Group at Hudson Institute
  • World-first trial of placental cell treatment helping premature babies

    A world-first therapy, developed at Hudson Institute of Medical Research and Monash University, using cells from the human placenta to repair the damaged lungs of premature babies, is giving hope to families of the most fragile infants like Harry Campbell. The results of a clinical trial at the Monash Children’s Hospital – the culmination of…  Read more

    Associate Professor Rebecca Lim and Dr Atul Malhotra stand before a premature baby, cradled in a humidicrib at Monash Health
  • Stunning NHMRC Grant success

    Hudson Institute has had outstanding success in the recent NHMRC Project Grant round. In addition, our researchers have been awarded an NHMRC Partnership Grant, an NHMRC Development Grant, an ARC Discovery Grant and three NMHRC Fellowships.…  Read more

    Professor Marcel Nold and A/Professor Claudia Nold from Hudson Institute of Medical Research
  • Associate Professor Claudia Nold receives academic promotion

    Claudia Nold, has received an academic promotion to Associate Professor from Monash University.…  Read more

    Associate Professor Claudia Nold from the Interventional Immunology in Early Life Diseases Research Group at Hudson Institute
  • Promising new treatment for incurable premature lung disease

    Hudson Institute researchers have discovered a potential safe and effective treatment for bronchopulmonary dysplasia (BPD), which could save preterm babies from the severe lifelong effects of this incurable premature lung disease.…  Read more

    Associate Professor Marcel Nold and Dr Claudia Nold and Dr Ina Rudloff from The Ritchie Centre at Hudson Institute of Medical Research.
  • Fielding Foundation Fellowship awarded to two emerging immunology research leaders

    The Fielding Foundation Fellowship 2017 has been jointly awarded to two outstanding immunology researchers at Hudson Institute, Dr Niamh Mangan, from the Centre for Innate Immunity and Infectious Diseases, and Associate Professor Marcel Nold, from The Ritchie Centre.…  Read more

  • Federal MP and local Mayor tour translational research facility

    Federal Member for Chisholm and former speaker, Anna Burke, and City of Monash Mayor, Cr Stefanie Perri, toured the Monash Health Translation Precinct’s (MHTP) new $84 million Translational Research Facility yesterday (Monday, February 15).…  Read more

    Anna Burke and City of Monash Mayor, Cr Stefanie Perri, toured the MHTP's new Translational Research Facility.
  • Hudson Institute researcher utilises Heart Foundation fellowship award

    Hudson Institute’s Dr Claudia Nold will use a competitive Heart Foundation Fellowship and Innovation Award to help develop new treatments for cardiopulmonary diseases in preterm babies.…  Read more

    Dr Claudia Nold will use a Heart Foundation Fellowship and Innovation Award to help develop new treatments for cardiopulmonary diseases. in preterm babies.
  • Premature baby research recognised for innovation

    Hudson Institute’s Dr Claudia Nold has been awarded a prestigious Paul Korner Innovation Award from the Heart Foundation for her research into dangerous diseases associated with premature birth.…  Read more

    Associate Professor Claudia Nold from the Interventional Immunology in Early Life Diseases Research Group at Hudson Institute